Aurigene Pharmaceutical Services offers a wide array of Discovery Chemistry Services to biotechnology, pharmaceutical, agrochemical, and specialty chemical firms. We accelerate drug discovery for our clients by providing multiple routes of synthesis and synthesizing compounds faster and integrating it with Biology Services. Our ready-to-use chemical inventory system enables faster delivery. We have a highly talented team of scientists who are Postgraduates or above and a world-class infrastructure of 300+ hoods, specialised labs like Oligonucleotides, Peptides and niche equipment like Electro and photo synthesizers which enables us to synthesize the most challenging compounds with ease. We also specialise in the synthesis of a library of compounds on a scale ranging from a few milligrams to multi-hundred grams. We have demonstrated an excellent track record of resolving challenging chemistry-related problems and conducting focused library searches to expedite discovery processes.
We offer end-to-end medicinal chemistry services for the discovery of small molecules and peptides.
Our solutions for a wide range of synthetic chemistry challenges are backed by our extensive experience in medicinal chemistry services and diversified research background.
We are a leading manufacturer and supplier of activated Methoxy Polyethylene Glycol (m-PEGs) for the conjugation of proteins, antibody fragments and peptides to improve the stability and the pharmacokinetic properties of drugs.
We offer a comprehensive pharmaceutical analytical services including method verification, development and validation, impurity identification and characterisations and isolation of impurities by preparative scale purification, reverse phase/normal phase, ion-exchange, or gel filtration chromatographic techniques.
We are vastly experienced in the synthesis of Proteolysis Targeting Chimeras (PROTAC) and partial PROTAC for targeted protein degradation, including the development and functionalization of various E3-ligase ligands such as CRBN, VHL, MDM2, and cIAP1.
With years of experience in small molecules, we can design molecules that overcome bioavailability challenges and build a fast-forward strategy for your oligo targets in therapeutic fields like oncology, inflammation, and anti-bacterial, etc.
We offer pharma and biotech companies a wide range of discovery and CDMO custom peptide synthesis services, such as Solid phase synthesis, Solution phase synthesis, Hybrid peptide synthesis.
20+ years of legacy in offering custom library synthesis of compounds and generating small to medium-sized custom libraries of target compounds for global clients.
We specialise in chemical synthesis of custom carbohydrates with an excellent track record of accelerating multiple projects for global clients. We are highly experienced in handling moisture-sensitive glycosylations, triflates, azide transfer and oxidations.
Our early phase development of small molecule services is designed to accelerate the journey of your clinical candidate from toxicology study to clinical stage.
from 100+ discovery
8+ IND candidates
Biology as well as
You are about to leave Aurigene Pharmaceutical Services and affiliates website. Aurigene Pharmaceutical Services assumes no responsibility for the information presented on the external website or any further links from such sites. These links are presented to you only as a convenience, and the inclusion of any link does not imply endorsement by Aurigene Pharmaceutical Services.
If you wish to continue to this external website, click Proceed.